by in
Entry Author Date Location
Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials 07/07/11 Boston
A San Diego Sampler from the War on Diabetes 06/24/11 San Diego
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank 06/03/11 San Diego
Biotech’s Missed Opportunity: Small-Town and Rural America 04/18/11 National
Arena Adds $35.5M 03/29/11 San Diego
Amylin and Takeda Suspend Obesity Study to Consider Metreleptin Data 03/16/11 San Diego
Vivus to Try Again By Year’s End 02/28/11 San Francisco
Orexigen Axes 40 Percent of Workforce After FDA Turns Down Obesity Drug 02/09/11 San Diego
What’s Brewing at Massive Health? A Chat with Newly Funded Co-Founders Sutha Kamal and Aza Raskin 02/02/11 San Francisco
Orexigen Fails to Win FDA Approval of Obesity Drug, Stock Crashes 02/01/11 San Diego
San Diego’s Fight Against Diabesity: The Photo Gallery 01/28/11 San Diego
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug 01/27/11 San Diego
Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News 01/27/11 San Diego
See You Tonight at “San Diego’s Fight Against Diabesity” 01/27/11 San Diego
Stealthy Elcelyx Therapeutics, Focused on Diabetes, Raises $6M 01/26/11 San Diego
Vivus Faces New Safety Issue 01/21/11 San Francisco
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News 01/20/11 San Diego
Sanford-Burnham, Receptos Join “San Diego’s Fight Against Diabesity” on Jan. 27 01/19/11 San Diego
San Diego’s Quest to Fight the “Diabesity” Epidemic, Coming Jan. 27 01/13/11 San Diego
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
Zafgen Weight Loss Drug Shows Promise in First Human Test 01/05/11 Boston
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27 12/27/10 San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010 12/27/10 Boston
Navy’s Goal Could Improve Economics of Biofuel Development, Arena Plans More Studies of Weight-Loss Drug, Lpath Signs Deal With Pfizer for Eye Drug, & More San Diego Life Sciences News 12/23/10 San Diego
Vivus Submits Document to FDA 12/14/10 San Francisco
FDA Panel Recommends Orexigen’s Obesity Drug, Sequenom Raises Capital, CommNexus Reorganizes Its Free Incubator, & More San Diego Life Sciences News 12/09/10 San Diego
Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug 12/07/10 San Diego
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive? 12/03/10 San Diego
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny? 11/22/10 San Diego
Ambit Files for IPO, Arena Pharmaceuticals Says Weight-Loss Drug on Track, ESRI Launches Medical Place History Map App, & More San Diego Life Sciences News 11/12/10 San Diego
Page 3 of 7 « previous page · next page »